Weekly Administration of 2-Chlorodeoxyadenosine in Patients With Hairy-Cell Leukemia: A New Treatment Schedule Effective and Safer in Preventing Infectious Complications

@inproceedings{Lauria1997WeeklyAO,
  title={Weekly Administration of 2-Chlorodeoxyadenosine in Patients With Hairy-Cell Leukemia: A New Treatment Schedule Effective and Safer in Preventing Infectious Complications},
  author={Francesco Nicola Lauria and Monica Bocchia and Giuseppe Marotta and Donatella Raspadori and Pier Luigi Zinzani and Damiano Rondelli},
  year={1997}
}
To the Editor: The treatment options for hairy-cell leukemia (HCL) have increased rapidly in the last 10 to 15 years. HCL patients currently can benefit from several agents such as α-interferon (α-IFN), deoxycoformycin (DCF), and 2-chlorodeoxyadenosine (2-CdA). Despite complete remission (CR) 

Topics from this paper.